tag:blogger.com,1999:blog-80633311036274502512012-02-12T02:16:59.606-08:00Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.comBlogger4231100tag:blogger.com,1999:blog-8063331103627450251.post-23585026341133668922011-09-25T07:48:00.001-07:002011-09-25T07:48:17.401-07:00

Postprandial blood glucose levels, but not fasting blood glucose, predict cardiovascular events and all-cause mortality in people with type 2 diabetes, according to 14 years of follow-up in the San Luigi Gonzaga Diabetes Study. HbA1c was also a predictor of both outcomes over the long term, according to Dr Franco Cavalot (University of Turin, Italy), who presented long-term follow-up data here

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-48393349972749972992011-09-13T10:16:00.001-07:002011-09-13T10:16:23.688-07:00

A parable is told of a farmer who owned an old mule. The mule fell into the farmer's well. The farmer heard the mule 'braying' - or - whatever mules do when they fall into wells. After carefully assessing the situation, the farmer sympathized with the mule, but decided that neither the mule nor the well was worth the trouble of saving. Instead, he called his neighbors together and told them

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-79260917310555177132011-08-22T08:46:00.000-07:002011-08-22T08:48:20.450-07:00

The heart-failure drug development field is so strewn with casualties that researchers tend to express caution rather than optimism when discussing new candidates. Hopes are stirring again, however, for an LVEF-boosting drug with mechanistic underpinnings and safety data suggesting it could be an effective, lower-risk alternative to conventional inotropic agents, and perhaps more. That potential

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-21644240049740446322011-08-18T20:27:00.000-07:002011-08-18T20:26:42.881-07:00

Inhibition of von Willebrand factor (vWF) activity with the investigational agent ARC1779 (Archemix, Cambridge, MA) has been shown to reduce cerebral embolization after carotid endarterectomy in a randomized trial. ARC1779 is an aptamer that inhibits the prothrombotic function of vWF by binding to the A1 domain of vWF, blocking its interaction with glycoprotein, the study authors, led by Dr 

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-35379173886481463022011-08-08T20:42:00.001-07:002011-08-08T20:42:06.451-07:00

Two new studies published this week confirm clinical recommendations that a deferred angioplasty strategy of nonculprit lesions should remain the standard interventional approach in patients with ST-segment elevation MI (STEMI) undergoing primary PCI. In the first study, an analysis of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS AMI)

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-87645548220723330342011-08-08T20:41:00.000-07:002011-08-08T20:40:59.530-07:00

 The US FDA has provided  with figures from its MAUDE database on erosions with Amplatzer septal-occluder devices (St Jude Medical) until July 21, 2011. This follows a report last week in which some doctors expressed concerns about the safety of these devices, particularly with regard to erosions. Karen Riley (Office of Public Affairs, FDA, Silver Spring, MD) told  that the FDA has received

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-76264442522174712142011-08-01T20:12:00.001-07:002011-08-01T20:12:39.307-07:00

Two preventive-medicine experts in the UK are crying foul over a recent and controversial meta-analysis that concluded cutting salt consumption would have no clear health benefits [1]. In a Comment published in the July 30, 2011 issue of the Lancet, Dr Feng J He (Queen Mary University, London, UK) and Dr Graham A MacGregor (Wolfson Institute of Preventive Medicine, Barts, London, UK) say that

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-74998710698078448772011-08-01T20:09:00.001-07:002011-08-01T20:09:26.434-07:00

 A new meta-analysis has found that low-molecular-weight heparins (LMWHs) are associated with a reduction in mortality and major bleeding rates in STEMI patients treated with primary PCI as compared with unfractionated heparin (UFH) [1]. And patients at greatest risk seem to derive the most benefit from LMWHs, report Dr Eliano Pio Navarese (Nicolaus Copernicus University, Bydgoszcz, Poland) and

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-69320336672360349552011-07-25T20:54:00.000-07:002011-07-25T20:55:07.406-07:00

After a protracted approval process in which the FDA twice postponed a decision on the drug, experts are reacting to news of the US approval of ticagrelor (Brilinta, AstraZeneca), the newest antiplatelet agent to hit the market. The drug was given the all-clear from the agency yesterday and is currently approved to reduce the risk of cardiovascular death and MI in patients with acute coronary

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-79682142531741398832011-07-10T05:54:00.001-07:002011-07-10T05:54:45.566-07:00

 The once-daily oral anticoagulant rivaroxaban (Xarelto, Bayer/Johnson & Johnson) has been approved by the US Food and Drug Administration for prevention of deep venous thrombosis (DVT) in the setting of knee- or hip-replacement surgery, Janssen Pharmaceuticals—which holds the drug's US marketing rights—announced today. Rivaroxaban, a factor Xa inhibitor, joins the direct thrombin inhibitor 

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-25927309977035452272011-06-14T22:43:00.001-07:002011-06-14T22:43:45.385-07:00

Twenty years ago, I drove a cab for a living. One time I arrived in the middle of the night for a pick up at a building that was dark except for a single light in a ground floor window. Under these circumstances, many drivers would just honk once or twice, wait a minute, then drive away. But I had seen too many impoverished people who depended on taxis as their only means of transportation.

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com1tag:blogger.com,1999:blog-8063331103627450251.post-55667471919604656582011-06-14T22:40:00.001-07:002011-06-14T22:40:30.601-07:00

 The Food and Drug Administration is recommending that physicians restrict prescribing high-dose simvastatin (Zocor, Merck) to patients, given an increased risk of muscle damage. The new FDA drug safety communication, issued today, states that physicians should limit using the 80-mg dose unless the patient has already been taking the drug for 12 months and there is no evidence of myopathy. "

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-5874719313608921392011-06-14T22:25:00.001-07:002011-06-14T22:25:23.419-07:00

A woman was waiting at an airport one night, with several long hours before her flight. She hunted for a book in the airport shops, bought a bag of cookies and found a place to drop. She was engrossed in her book but happened to see, that the man sitting beside her, as bold as could be. . .grabbed a cookie or two from the bag in between, which she tried to ignore to avoid a scene. So she

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-78055863949002660892011-06-14T22:19:00.001-07:002011-06-14T22:19:19.950-07:00

One day, a poor boy who was selling goods from door to door to pay his way through school, found he had only one thin dime left, and he was hungry. He decided he would ask for a meal at the next house. However, he lost his nerve when a lovely young woman opened the door. Instead of a meal he asked for a drink of water. She thought he looked hungry so brought him a large glass of milk. He drank

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-19158220136634152302011-03-16T23:09:00.001-07:002011-03-16T23:09:25.070-07:00

In 1883, a creative engineer named John Roebling was inspired by an idea to build a spectacular bridge connecting New York with the Long Island. However bridge building experts throughout the world thought that this was an impossible feat and told Roebling to forget the idea. It just could not be done. It was not practical. It had never been done before. Roebling could not ignore the vision he

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-61907997916361229472011-03-16T21:17:00.001-07:002011-03-16T21:17:42.449-07:00

The Japanese have a great liking for fresh fish. But the waters close to Japan have not held many fish for decades. So, to feed the Japanese population, fishing boats got bigger and went farther than ever. The farther the fishermen went, the longer it took to bring back the fish. The longer it took them to bring back the fish, the staler they grew. The fish were not fresh and the Japanese did

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-42117699305510730202011-03-03T23:31:00.001-08:002011-03-03T23:31:52.238-08:00

In a futuristic project that might one day allow physicians to respond much more quickly to asymptomatic MIs, researchers at MIT have developed a tiny, subcutaneous sensor that can detect elevations of myoglobin, cardiac troponin I, and creatine kinase. Not only can these minute implanted sensors pick up on an MI as muscle damage begins, they can also capture the extent of damage after the fact

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-64597323247695903802011-03-03T23:26:00.001-08:002011-03-03T23:26:10.986-08:00

Panacea Biotec Limited, India’s 3rd largest biotech company has signed a non-exclusive marketing agreement with Laboratorios Clausen S.A, Uruguay. The agreement will give an access to Laboratorios Clausen S.A to market Panacea Biotec Limited’s “Tacrolimus” (Pangraf) in few markets in Europe. The agreement was signed on March 3 in the presence of Danilo Astori, vice president of the Oriental

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-23659874840245425192011-03-03T23:25:00.001-08:002011-03-03T23:25:53.865-08:00

Strides Arcolab has entered into an understanding with Aspen to acquire the facility in Campos, Brazil with related products and IPs for a total consideration of US$75 million. The Campos facility is engaged in producing penems and penicillins. It was originally divested to Aspen in 2007 at the time when company exited from LATAM operations.  The facility is likely to generate income of US$ 40

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-36391618790636778622011-03-03T20:06:00.000-08:002011-03-03T20:09:32.740-08:00

 

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-26334957558848990572011-02-25T19:56:00.001-08:002011-02-25T19:56:53.616-08:00

Italian registry data confirm the so-called "valve-in-valve" technique for repairing malpositioned CoreValve (Medtronic, Minneapolis, MN) transcatheter aortic valves is a good option for patients with significant paraprosthetic leaks without recourse to surgery. Dr Gian Paolo Ussia (University of Catania, Italy) and colleagues reviewed 663 consecutive patients who underwent transcatheter

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-3561747685596707032011-02-25T19:53:00.001-08:002011-02-25T19:53:16.777-08:00

It's time to acknowledge the pile of evidence that light to moderate alcohol consumption is not only good for cardiovascular health, it could potentially be recommended for CV risk reduction, according to authors of two meta-analyses published online February 22, 2011 in BMJ. An analysis of prospective cohort studies showing alcohol effects on cardiovascular end points, with first author Dr

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-36231994428205530382011-02-24T03:08:00.001-08:002011-02-24T03:08:41.421-08:00

As Actor and Director Sylvester Stallone has rightly said it in the movie ‘Rocky Balboa’: “The world ain’t all sunshine and rainbows. It’s a very rough, mean place. And no matter how tough you think you are, it will always bring you to your knees and keep you there permanently if you let it. You or nobody ain’t gonna hit as hard as life. But it ain’t about how hard you hit. It’s about how hard

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-15793434405580940152011-02-17T19:58:00.001-08:002011-02-17T19:59:15.044-08:00

Adults receiving a transplant because of congenital heart disease are more likely to die within a month than other transplant patients, suggesting that these patients ought to be listed for transplant earlier, a review of registry data shows.Dr Ryan Davies (Columbia University, New York, NY) and colleagues analyzed records of 41 849 adult patients listed for primary transplantation between 1995

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-88823016103824057092011-02-14T20:42:00.001-08:002011-02-14T20:42:11.393-08:00

Both short and long duration of sleep are predictors or markers of cardiovascular outcomes, a new review suggests [1]. The review, published online February 7, 2011 in the European Heart Journal, included 15 prospective studies in a total of 474 684 participants and shows an increased risk of developing or dying of CHD and stroke on either end of the distribution of sleep duration. But results

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-48917831692923032132011-01-26T19:14:00.001-08:002011-01-26T19:14:10.562-08:00

On 3rd December 1971 we fiercely and vigorously attacked the Indian army with infantry brigade near Hussainiwala border. This brigade included Pakistan army’s Punjab regiment together with the Baloch regiment. Within minutes we pushed the Indian army quite far back. Their defense posts fell under our control. The Indian army was retreating back very fast and the Pakistani army was going forward

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com1tag:blogger.com,1999:blog-8063331103627450251.post-73002033958695199652011-01-26T05:38:00.001-08:002011-01-26T05:38:50.678-08:00

A gentleman was once visiting a temple under construction. In the temple premises, he saw a sculptor making an idol of God. Suddenly he saw, just a few meters away, another identical idol was lying. Surprised he asked the sculptor,” do you need two statutes of the same idol?” Said the sculptor, “we need only one, but the first one got damaged at the last stage.” The gentleman examined the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-4153730492534648682011-01-26T05:37:00.001-08:002011-01-26T05:37:50.484-08:00

When a male teacher misbehaves with a girl student, a policeman robs a helpless citizen or a man in the garb of a saint, assaults a woman it raises more indignation. And rightly so, because they have broken the trust placed in them which they enjoy by virtue of their position. They are guilty on two counts, one of committing a horrendous act and the other of breach of trust. There is a piece

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-85670689465470908002011-01-26T05:30:00.001-08:002011-01-26T05:30:08.522-08:00

A Persian folktale called “Marvarid” (The Pearl) high-lights the virtue of patience that sadhus, bhikshus, hermits and sufis achieved. A poor god-fearing man and his wife earned their livelihood by spinning cotton into thread and selling it in the market. One day, as the man came home from the market, he met a friend who was in dire need. The good man gave his day’s earning to his friend and

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-88217727292728934722011-01-26T05:26:00.001-08:002011-01-26T05:26:42.435-08:00

Once a king called upon all of his wise men and asked them, “ Is there a mantra or suggestion which works in every situation and place, every joy and sorrow, every defeat and victory. I need only one answer for all questions? I am looking for something which can help me, when none of you is available to advise me or guide me? Tell me is there any mantra?” All the wise men were puzzled by the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-9366398027914804942011-01-19T04:14:00.001-08:002011-01-19T04:14:43.436-08:00

There was once a great scholar. Everybody in the kingdom appreciated him because he was so learned. Unfortunately, inspite of his great learning he had great pride. One day,this scholar put on a gold necklace and went to the palace of another king. He said, “Whoever can defeat me in wisdom will get this necklace. I challenge everybody!” All the scholars in that particular kingdom had heard

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-39086584650242867162011-01-13T20:42:00.001-08:002011-01-26T20:30:53.674-08:00

Sleep deprivation can addle someone just as much as a bottle of whiskey and therefore justifies regulations to protect patients from yawning surgeons, asserts a recent editorial in the New England Journal of Medicine.For one thing, surgeons who have been awake for 22 of the past 24 hours could be required by law to disclose their condition to patients scheduled for elective surgery, who could

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-26493458403290597482011-01-09T20:59:00.001-08:002011-01-09T20:59:50.792-08:00

 Having recently been shown ineffective in the treatment of MI, the focus on glucose-insulin-potassium (GIK) appears to be shifting to myocardial protection during cardiac surgery, with early results in this indication looking promising [1]. In the latest study, perioperative use of a GIK solution has shown benefits in patients with left ventricular hypertrophy undergoing aortic-valve

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-3069075905979302692011-01-09T20:57:00.001-08:002011-01-09T20:57:49.586-08:00

AngioSculpt percutaneous transluminal angioplasty (PTA) scoring balloon catheters, manufactured by AngioScore, are subject to a class I US Food and Drug Administration(FDA) recall due to complaints of retained device fragments or significant arterial injury, which may lead to death or the need for additional surgical intervention [1]. The FDA issued the safety alert from the MedWatch FDA

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-56093365622389027932011-01-03T21:02:00.001-08:002011-01-03T21:02:31.867-08:00

Once a wise woman who was traveling in the mountains found a precious stone in a stream. The next day she met another traveler who was hungry, and the wise woman opened her bag to share her food. The hungry traveler saw the precious stone and asked the woman to give it to him. She did so without hesitation. The traveler left, rejoicing in his good fortune. He knew the stone was worth enough to

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com1tag:blogger.com,1999:blog-8063331103627450251.post-61070263201153952302011-01-03T01:34:00.001-08:002011-01-03T01:34:56.159-08:00

Low levels of HDL-cholesterol levels, despite treatment with statin therapy for elevated LDL-cholesterol levels, remains a significant risk factor for cardiovascular events, according to a new analysis [1]. The inverse relationship between HDL-cholesterol levels and cardiovascular outcomes remained significant even after adjustment for on-treatment LDL-cholesterol levels, age, hypertension,

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-18546249873339046652011-01-03T01:19:00.003-08:002011-01-03T01:19:48.630-08:00

Women who consumed at least 102 g of red meat a day had a 42% higher risk of cerebral infarction than those who ate 25 g or less daily in a new analysis [1]. The findings "suggest that consumption of red and processed meats may increase risk of cerebral infarction," the authors, led by Dr Susanna C Larsson, (National Institute of Environmental Medicine, Stockholm, Sweden), conclude. "These

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-28921505602786493592011-01-03T01:19:00.001-08:002011-01-03T01:19:45.441-08:00

Predictive factors for developing candidemia in patients undergoing cardiac surgery are more or less the same as those of the general intensive-care-unit (ICU) population, according to the findings of a new prospective observational study [1]. Dr Daniela Pasero (University of Turin, Italy) and colleagues reported their findings online December 22, 2010 in Interactive Cardiovascular and

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-18180168278766394572010-11-29T21:49:00.001-08:002010-11-29T21:49:17.367-08:00

Ethyl eicosapentaenoic acid (EPA), a semisynthetic derivative of omega-3 fatty acids, significantly lowers triglyceride levels in patients with very high triglyceride levels without significantly increasing LDL-cholesterol levels. Top-line results of the MARINE trial, a randomized, placebo-controlled trial testing ethyl-EPA in 229 patients with triglyceride levels >500 mg/dL, were announced

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-24223393398502549732010-11-28T20:47:00.001-08:002010-11-28T20:47:14.462-08:00

Patients with stable coronary artery disease (CAD) who require single antiplatelet therapy and who are nonresponsive to aspirin should probably switch to clopidogrel, says the lead author of a new study, Aspirin Nonresponsiveness and Clopidogrel Endpoint (ASCET), which was presented at the American Heart Association (AHA) 2010 Scientific Sessions last week. The discussant of the trial agrees

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-75810970234680126292010-11-28T20:43:00.001-08:002010-11-28T20:43:36.103-08:00

One day, a man saw an old lady, stranded on the side of the road, but even in the dim light of day, he could see she needed help. So, he went up to her Mercedes. Even with the smile on his face, she was worried. No one had stopped to help for the last hour or so. Was he going to hurt her? He didn’t look safe; he looked poor and hungry. He could see that she was frightened. He said, “I’m here to

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-10292680048956946262010-11-12T21:29:00.001-08:002010-11-12T21:29:07.000-08:00

On the first day, as President, Abraham Lincoln entered to give his inaugural address, just in the middle, one man stood up. He was a rich aristocrat. He said, “Mr. Lincoln, you should not forget that your father used to make shoes for my family”. And the whole senate laughed; they thought they had made a fool of Abraham Lincoln. But Lincoln—and that type of people are made of a totally

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-77071295515439161022010-11-12T21:17:00.001-08:002010-11-12T21:17:10.592-08:00

Non-ST-segment-elevation-MI (NSTEMI) patients take too long to get to the hospital once they experience their first symptoms, according to the results of a new analysis. Overall, more than half of the patients took more than two hours to get to the hospital, and investigators say new strategies are needed to get patients to seek care, given that delay times have not improved in recent years.

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-70422553238122943292010-11-07T19:12:00.001-08:002010-11-07T19:12:40.718-08:00

Secret of Success A young man asked Socrates about what was the secret of success. Socrates told the young man to meet him near the river the next morning and he would show him. When they met the next morning, Socrates asked the young man to walk with him towards the rivers edge and then into the water. When the water got up to their neck, Socrates took the young man by surprise and pushed

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-90747158863154184392010-11-06T00:53:00.001-07:002010-11-06T00:53:28.950-07:00

se of recombinant activated factor VII (rFVIIa) (NovoSeven, Novo Nordisk) on an off-label basis significantly increases the risk of arterial thromboembolic events, especially among the elderly, a new report shows. The analysis of data from 35 randomized placebo-controlled trials, published in the November 4, 2010 issue of the New England Journal of Medicine, was conducted by a team led by Dr

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-45476464865594926982010-11-06T00:52:00.001-07:002010-11-06T00:52:15.471-07:00

 A meta-analysis of current relevant research provides more evidence of opposing effects of vitamin E on stroke subtypes. The researchers found a 22% increased risk of hemorrhagic stroke and a 10% decreased risk of ischemic stroke with vitamin-E supplementation, although the absolute effects are small. The findings were published online November 4, 2010 in BMJ. "Vitamin-E supplementation does

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-67194498381808521392010-11-03T22:12:00.001-07:002010-11-03T22:12:08.564-07:00

An old man lived alone in a village. He wanted to spade his potato garden, but it was a very hard work. His only son, who would have helped him, was in prison. The old man wrote a letter to his son and mentioned his situation: Dear Son, I am feeling pretty bad because it looks like I won’t be able to plant my potato garden this year. I hate to miss doing the garden, because your mother always

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-9703135987956037492010-11-03T21:59:00.001-07:002010-11-03T21:59:36.566-07:00

Sometimes ago, scientist carried out a simple experiment on a barracuda (marine fish). They put the barracuda into a big glass aquarium and began to feed the barracuda with small fishes. The barracuda would swim towards the small fishes and in one gulp would swallow them. They continued putting the small fishes into the glass container as food for the barracuda. Then one day the scientist put a

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-41338136279105608842010-11-03T21:52:00.001-07:002010-11-03T21:52:38.120-07:00

There once lived a great mathematician in a village outside Ujjain. He was often called by the local king to advice on matters related to the economy. His reputation had spread as far as Taxila in the North and Kanchi in the South. So it hurt him very much when the village headman told him, “You may be a great mathematician who advises the king on economic matters but your son does not know the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-61149916403738077042010-10-29T21:16:00.003-07:002010-10-29T21:19:29.645-07:00

Pfizer is recalling two additional lots of atorvastatin (Lipitor) 40 mg, or approximately 38 000 bottles, because of "customer reports of an uncharacteristic odor related to the bottles in which these lots of Lipitor were packaged.Earlier this month, Pfizer reported that it had recalled seven lots of atorvastatin for the same reason.Like the earlier recall, the company said the odor is consistent

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-28978992098067035182010-10-29T21:16:00.001-07:002010-10-29T21:16:27.626-07:00

The Canadian Cardiovascular Society (CCS) has issued guidelines, the first of their kind anywhere, specific to the use to antiplatelet therapy, including their use in multiple settings, such as primary and secondary prevention, as well as following PCI, CABG surgery, and in patients with peripheral arterial disease and diabetes. The evidence-based document is intended for practical use and is

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-66793177984864991372010-10-19T19:56:00.001-07:002010-10-19T19:56:40.499-07:00

Despite a comparable number of percutaneous coronary intervention (PCI) procedures performed in the United States and in Europe, European countries have much higher rates of transradial PCI -- an approach associated with decreased vascular complication risk, improved outcomes, shorter hospital stays, lower costs, and increased patient satisfaction compared with transfemoral PCI. But barriers to

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-77361489886600992412010-10-16T21:56:00.001-07:002010-10-16T21:56:59.853-07:00

A new meta-analysis involving tens of thousands of patients challenges the validity of a pharmacogenomic assay marketed as a way to identify patients who might respond especially well to statin therapy, according to its authors and an accompanying editorial. The study, published online October 6, 2010 in the Journal of the American College of Cardiology, found no significant relationship

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-83318928653679827102010-10-16T21:55:00.001-07:002010-10-16T21:55:19.788-07:00

The idea that prior aspirin use by those who develop an ACS may actually predispose to worse outcomes does not appear to be a true phenomenon, and use of aspirin is more likely just a marker of a high-risk group, according to new results from the TIMI database including more than 66 000 ACS patients. In a paper in the October 19, 2010 issue of the Journal of the American College of Cardiology,

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-35873541823665022472010-10-16T21:39:00.000-07:002010-10-16T22:42:56.628-07:00

"The Guru Gayatri of Guru Gobind Singh has the power of the four Vedas, six Puranas and 36 Simritis. All these are equal to reciting the Guru Gayatri just once. Traditionally, only a person who has been initiated by a guru is entitled to chant a gayatri. First you have to find a guru, one with God consciousness, and then he needs to initiate you. Only then are you entitled to chant the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-86546345083562702202010-10-02T23:35:00.001-07:002010-10-02T23:35:20.443-07:00

For patients younger than age 75 with asymptomatic carotid stenosis, successful carotid endarterectomy (CEA) reduces the risk of stroke over the next 10 years by about 46%, with about half of this reduction in disabling or fatal strokes, suggest the Asymptomatic Carotid Surgery Trial-1(ACST-1) results published September 25, 2010 in the Lancet. However, the perioperative risk of stroke or

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-79942365063350084752010-09-19T20:07:00.001-07:002010-09-19T20:07:16.128-07:00

The first randomized, double-blind, placebo-controlled US trial of bone-marrow stem cells in patients with ST-elevation MI (STEMI) has shown the therapy to be safe and to improve left ventricular volume compared with placebo. Dr Jay H Traverse (Minneapolis Heart Institute, MN) and colleagues report the findings in the September 2010 issue of the American Heart Journal. Traverse told that this

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-51756551415099162272010-09-19T20:02:00.001-07:002010-09-19T20:02:55.759-07:00

In patients with atrial fibrillation (AF), combinations of warfarin, aspirin, and clopidogrel are associated with increased risks of serious nonfatal and fatal bleeding, with dual warfarin and clopidogrel therapy and triple therapy carrying a more than three-fold higher risk than warfarin alone, a new Danish study shows. But such treatment does not appear to be associated with a significant

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-16700687221242761632010-09-15T20:35:00.001-07:002010-09-15T20:35:15.187-07:00

Dr. Jeff Carstens knows the reaction he'll get when he mentions open heart surgery to a patient. “They say, whoa, ‘I don't want to have that,'” said Carstens, an Omaha cardiologist. Patients may balk, but a new study indicates that heart bypass surgery may be a better option than stents for many people with heart disease. Researchers involved in the major European-American study say that

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-36290760575036338272010-09-13T20:14:00.001-07:002010-09-13T20:14:53.871-07:00

 Dr V Nandakumar, chief cardiac surgeon at the Kovai Medical Centre in Coimbatore has performed a rare cardiac surgery on Ramaswamy, a chronic renal patient.   "I wanted to make sure that Ramaswamy of Tirupur is perfectly normal before disclosing it to the outside world. Now, more than a month has passed after the surgery and the patient is perfectly normal," Dr Nandakumar, who had worked as

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-66160008021365875372010-09-08T20:03:00.000-07:002010-09-08T20:04:00.442-07:00

In Consumer Reports, alongside toasters, oven and cars, medical groups that perform heart bypass surgery are now being rated. Data-based ratings of doctors are not available to patients in most parts of the country, data-based except a few states like New York. From 42 states, ratings of 221 surgical groups were published but it should be noted that individual doctors are not rated. Based on

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-13385126630398586152010-09-08T20:02:00.001-07:002010-09-08T20:02:46.182-07:00

Cardiac surgery-associated acute kidney injury (CSA-AKI) contributes to increased morbidity and mortality. However, its pathophysiology remains incompletely understood. We hypothesized that intra-operative mean arterial pressure (MAP) relative to pre-operative MAP would be an important predisposing factor for CSA-AKI. Methods: We performed a prospective observational study of 157 consecutive

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-67553318013873429282010-09-07T20:11:00.001-07:002010-09-07T20:11:21.796-07:00

Cardiac surgery patients with impaired glucose tolerance or prediabetes have long been thought to suffer more major postoperative adverse events than those with normal glucose tolerance. New evidence suggests that may not be the case. Researchers in Boston have found that the two groups of patients—prediabetics and nondiabetics—experience similar rates of myocardial infarction, renal failure,

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-5930347791321111622010-09-07T00:03:00.000-07:002010-09-07T00:04:02.845-07:00

Rewarming of blood after hypothermic cardiopulmonary bypass appears to impair autoregulation of blood flow in the brain, increasing the patient’s risk for stroke in the process, researchers have found. Investigators at Johns Hopkins University in Baltimore found that patients with impaired autoregulation of cerebral blood during rewarming were four times as likely to experience a stroke or

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-26607440683891214392010-09-06T23:47:00.000-07:002010-09-06T23:48:07.313-07:00

  Since the removal of aprotinin from the market in late 2007, tranexamic acid and ε-aminocaproic acid have been used interchangeably. Yet clinicians have had little data comparing the relative safety and effectiveness of the two drugs on which to base their choice of blood-loss agent.  Results from two studies, one ongoing, should help.   Interim analysis of the continuing trial, by

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-85291183521495124862010-09-05T21:05:00.001-07:002010-09-05T21:05:44.734-07:00

The crucial decision on banning a number of controversial drugs, which have been either restricted or withdrawn in many countries, continues to be delayed inordinately with the Drug Technical Advisory Board (DTAB) still sitting on the matter and the health ministry ruling out any action without a recommendation from the DTAB.  The Health Ministry sources told that the matter was still with the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-24807214359619120842010-09-05T20:57:00.000-07:002010-09-05T20:58:03.311-07:00

About 7 to 8 per cent of households in the country are pushed below the poverty line every year because of expenses incurred on healthcare, according to India Health Report 2010 prepared by Confederation of Indian Industry (CII) and Indicus Analytics. The India health Report, released recently, also said that the contribution of the private sector in terms of the availability of hospital beds

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-84899272445146475402010-09-03T22:55:00.000-07:002010-09-03T22:55:04.060-07:00

The significant survival gains from cardiac resynchronization therapy (CRT) seen within the first year or two of Cardiac Resynchronization in Heart Failure (CARE-HF), one of the seminal randomized trials that established the heart-failure device therapy as mainstream, persisted for seven years or more, according to a long-term follow-up of the trial, one of the longest of its kind. Nearly all

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-54914464961927053712010-09-02T20:17:00.001-07:002010-09-02T20:17:30.730-07:00

Drug-eluting stents (DES) for primary intervention in acute-MI patients appear to remain unpopular, although at least one expert believes the evidence favors them over bare-metal stents for this indication. In a formal debate here at the European Society of Cardiology (ESC) 2010 Congress, Dr Manel Sabate (Hospital de Sant Pau, Barcelona, Spain) argued that DES should be used routinely for

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-81717527832714843362010-09-02T20:14:00.001-07:002010-09-02T20:14:11.048-07:00

Another cardiologist in Maryland has been accused of performing unwarranted procedures on multiple patients over a number of years. Dr John R McClean has been indicted on fraud charges by a federal grand jury in Baltimore; he allegedly placed hundreds of stents that were not needed and carried out unnecessary ECGs, echoes, and nuclear stress tests worth millions in combined Medicare payments,

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-10741905956335585392010-08-31T20:27:00.001-07:002010-08-31T20:27:30.717-07:00

Patients with atrial fibrillation unable to take warfarin who are treated with apixaban (Pfizer/Bristol-Myers Squibb), an investigational oral factor Xa inhibitor, had a significantly lower risk of stroke and systemic embolic events compared with patients treated with aspirin. Importantly, the benefits of apixaban did not come at a cost of increased bleeding, with no observed increases in the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-24037342866760708692010-08-30T20:36:00.001-07:002010-08-30T20:36:56.241-07:00

 A novel antiplatelet agent tested in a phase 2 trial passed safety and clinical hurdles this week when investigators showed that treatment with oral and intravenous (IV)elinogrel (Novartis) had more rapid antiplatelet effects than clopidogrel (Plavix, Bristol Myers-Squibb/Sanofi-Aventis) in the acute and chronic phases of therapy. "I think, at this point, we're talking about potential

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-1613072393420084112010-08-30T20:35:00.001-07:002010-08-30T20:35:18.090-07:00

 A new investigational antiplatelet agent, atopaxar (E5555; Eisai)—which acts via a different pathway from that of aspirin and drugs such as clopidogrel and ticagrelor—has shown promising results in a two-arm phase 2 trial in Japan, one part in ACS patients and the other in people with high-risk CAD.   The findings, which were published simultaneously in the European Heart Journal,were

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-75958314150376529762010-08-30T20:33:00.000-07:002010-08-30T20:34:02.669-07:00

One-year data from what the lead investigator characterized as one of the largest-ever randomized clinical trials of two CABG surgery techniques has found no differences in major clinical events between patients treated with either single internal mammary artery (SIMA) grafts or bilateral internal mammary arteries (BIMA). Presenting the results here at the European Society of Cardiology 2010

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-2954755143120445462010-08-30T20:27:00.000-07:002010-08-30T20:28:02.047-07:00

More than two decades into the era of primary PCI, alternatives to unfractionated heparin (UFH) as the procedure's antithrombin adjuvant have been explored far less thoroughly than, say, what form of antiplatelet therapy might be best during the procedure. Now a prospective, randomized trial appears to strengthen observational evidence that the low-molecular-weight heparin (LMWH) enoxaparin (

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-47900404571154585202010-08-29T21:25:00.000-07:002010-08-29T21:26:01.325-07:00

Researchers believe they may have found a truly reversible anticoagulant system to control bleeding during PCI that consists of one agent to anticoagulate and another to halt the first drug's effects. The product, known for the time being as REG1 (Regado Biosciences, Basking Ridge, NJ) includes two nuclease-stabilized RNA aptamers: an aptamer inhibiting coagulation factor IXa called RB006 (

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-918588059527476522010-08-29T21:04:00.000-07:002010-08-29T21:05:00.585-07:00

The largest clinical trial so far of intracoronary autologous stem-cell transplantation in patients with chronic heart failure has shown that such treatment was associated with multiple hemodynamic and functional benefits as well as a reduction in mortality, benefits that were maintained out to five years of follow-up. The STAR-heart study was presented today at the first clinical-trial

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-86786490653304108812010-08-28T21:05:00.001-07:002010-08-28T21:05:50.661-07:00

Imagine 10 surgeries at one sitting with a single anaesthesia within seven hours. This is precisely what doctors at Manipal Hospital did. The result: Fifty-nine-year-old Nagamma, who suffered from 15 years of chronic crippling disabilities, is now able to walk without pain. The surgery is believed to be the first of its kind in India, if not globally. A team of three doctors conducted the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-78979730044874521422010-08-27T19:34:00.001-07:002010-08-27T19:34:06.816-07:00

When Doris Snyder celebrated her 102nd birthday on August 10, she was that much closer to the expected birth of her first great-granddaughter who's due to arrive early September. She is very excited about the milestone, which might not have been possible were it not for a cutting-edge, experimental procedure that replaced one of Doris' heart valves weeks earlier when she was 101. The valve had

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-14704641621990092582010-08-26T19:40:00.001-07:002010-08-26T19:40:59.274-07:00

Doctors at St. Louis Children’s Hospital say Owen Stark, a 2-year-old from Eldon, MO, is alive today because of an artificial lung. St. Louis Children’s Hospital is the first hospital in the country to use the device, the German-made Novalung® sLA Membrane Lung, as an artificial lung. Owen is the youngest person in the world to receive one. Originally approved to help adults through cardiac

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-19726932292706581442010-08-25T22:30:00.001-07:002010-08-25T22:30:45.524-07:00

Inserting a sponge containing gentamicin antibiotic at the time of surgical closure following cardiac surgery does not reduce the rate of sternal wound infections after three months, according to US researchers. The findings contradict evidence from previous studies. Use of the sponges is currently approved in 54 countries. The trial included 1,502 cardiac surgical patients at high risk for

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-90156828269597053742010-08-25T22:23:00.001-07:002010-08-25T22:23:18.621-07:00

In a pathbreaking cardiac surgery, doctors at a city hospital have successfully removed over 20gm of muscle bulge from the outlet of the heart of an 11-year-old boy.  The bulge was obstructing the flow of blood from Ravi Ramola's heart to other parts of the body due to which his physical growth was affected. Doctors at Sir Ganga Ram Hospital, who performed the surgery, said such an obstruction

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-81969407248819319422010-08-25T21:20:00.001-07:002010-08-25T21:20:37.247-07:00

Vyteris, a developer of transdermal drug delivery technology, has announced an agreement with the Georgia Tech Research Corporation of the Georgia Institute of Technology, or Georgia Tech, granting Vyteris the option to exclusively license Georgia Tech's patented thermal ablation and microdevice fabrication technologies for transdermal drug delivery. Under terms of the agreement, Georgia Tech

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-56625026343404524162010-08-25T20:13:00.001-07:002010-08-25T20:13:50.781-07:00

Cipla, the third largest pharma company in India with net sales of Rs 5,300 crore plus, has acquired Meditab Specialities Pvt Ltd for a total consideration of Rs 133.35 crore. Meditab has small and mid-sized formulation manufacturing facilities at multiple locations. Entities controlled by the relatives of the promoters are major shareholders in Meditab. The aggregate consideration for this

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-51266872714177307012010-08-18T20:42:00.001-07:002010-08-18T20:42:57.762-07:00

I would like to comment that in the times of adversity there is no religion; Hindu, Sikh, Muslim, Christan and No Country whether it is India or Pakistan. The only religion which Should prevail at these trying times is that of Humanity….   Keeping this tradition alive, Indian government has extended a relief package of US$5.0 million which is far more than any help extended by any Western

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-80338746509492616362010-06-09T21:30:00.001-07:002010-06-09T21:30:58.219-07:00

CytRx Corporation, a biopharmaceutical company specializing in oncology, has been granted by the US Patent and Trademark Office (US PTO) of US Patent 7,728,131 for oncology drug candidate bafetinib, encompassing claims related to bafetinib's pharmaceutical compound and composition in all indications, as well as for use in methods for treating acute and chronic myelogenous leukaemia and acute

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-33265422968413798692010-06-09T21:28:00.001-07:002010-06-09T21:28:24.903-07:00

The Board of Directors of Fortis Healthcare, the largest private healthcare network in Asia, has approved the proposal to raise additional funds of Rs 2,750 crore by way of issuance of further securities. The company will take final decision regarding specific instrument, size and timing of issue of securities after advice of merchant bankers, book runners and lead managers.  Further, the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-26805650233585457762010-02-08T08:34:00.000-08:002010-02-08T08:35:08.507-08:00

ਬਸੰਤ ਕੀ ਵਾਰ ਮਹਲੁ ੫ basant kee vaar mahal 5 Basant Kee Vaar, Fifth Mehl: ੴ ਸਤਿਗੁਰ ਪ੍ਰਸਾਦਿ ॥ ik-oNkaar satgur parsaad. One Universal Creator God. By The Grace Of The True Guru: ਹਰਿ ਕਾ ਨਾਮੁ ਧਿਆਇ ਕੈ ਹੋਹੁ ਹਰਿਆ ਭਾਈ ॥ har kaa naam Dhi-aa-ay kai hohu hari-aa bhaa-ee. Meditate on the Lord's Name, and blossom forth in green abundance. ਕਰਮਿ ਲਿਖੰਤੈ ਪਾਈਐ ਇਹ ਰੁਤਿ ਸੁਹਾਈ ॥ karam likhantai paa-ee-ai

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-10177935647085243042010-01-31T08:10:00.001-08:002010-01-31T08:10:54.745-08:00

I am not sure about SRK’s remark for bringing peace to IPL imbroglio. But where was Shiv Sena with its neonate MNS, when 26/11 unfortunately happened??? They all were hiding behind the secure walls of their villas. It were the North Indians (NSG commandos flew from New Delhi), who bravely confronted the perpetrators of hatred and brought costly peace to Mumbai.   Now they proudly talk about

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-43506472261979822082010-01-09T22:27:00.001-08:002010-01-09T22:27:35.745-08:00

The bivalent vaccine (bOPV) is being introduced in the country for the first time in Bihar from tomorrow which is National Immunization Day (NID) for pulse polio campaign. President Pratibha Devisingh Patil launched the NID by administering polio drops to ten babies at Rashtrapati Bhawan in Delhi today.  Speaking on the occasion the Union Minister of Health and Family Welfare Ghulam Nabi Azad

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-4871374175345157422010-01-09T22:25:00.003-08:002010-01-09T22:25:55.355-08:00

Biovel Lifesciences, a bio pharmaceutical start-up venture, is all set to be acquired by Ranbaxy. The final deal is yet to be inked and is expected to be over by this weekend. The value of the deal could be around Rs 50 crore, stated sources close to the development. This is for the second time that Ranbaxy is acquiring a unit in South. The company had earlier acquired a majority stake in

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-18521166472595564942010-01-09T22:25:00.001-08:002010-01-09T22:25:42.772-08:00

AkaRx Inc., a privately held drug development company ("AkaRx") announced today the closure of its acquisition by Eisai Inc. ("Eisai") of Woodcliff Lake, NJ for $255 Million. With today's closing, AkaRx becomes a wholly-owned subsidiary of Eisai, the US subsidiary of Tokyo-based Eisai Co., Ltd. The founding team of AkaRx has since founded a second company, Drais Pharmaceuticals Inc. that like

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-7830794991416918082010-01-09T22:22:00.001-08:002010-01-09T22:22:30.767-08:00

Indian pharmaceutical company Cipla is negotiating with multinational and generic drug companies including GlaxoSmithKline, or GSK, a UK-based pharmaceutical company, and Teva, an Israeli pharmaceutical company, to provide generic drugs, according to Reuters. Cipla was previously in talks with numerous pharmaceutical companies including Pfizer to supply generic drugs. Cipla said it was in

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-73397486645892414282010-01-05T05:36:00.001-08:002010-01-05T05:36:11.791-08:00

London's Royal Free Hospital used nanotechnology to develop the small bypass graft from a polymer material.   The material enables the graft to mimic the natural pulsing of human blood vessels, which enables them to deliver nutrients to the body's tissues.   The ultimate aim is to use the graft in coronary artery and lower-limb arterial surgery, which doctors say could reduce amputations

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-47166051520964151162009-12-24T23:20:00.000-08:002009-12-24T23:21:02.945-08:00

Seattle Genetics has entered into a collaboration agreement with GlaxoSmithKline or GSK under which GSK will pay an upfront fee of $12 million for rights to utilize Seattle Genetics's antibody-drug conjugate or ADC technology with multiple antigens to be named by GSK. GSK is responsible for research, product development, manufacturing and commercialization of all ADC products under the

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-4021983617224506512009-11-15T16:29:00.001-08:002009-11-15T16:29:35.200-08:00

Danish LEO Pharma has gained additional ground in the US after finalising the agreement to acquire Australian-US Peplin, Inc. It was announced that Peplin, Inc and LEO Pharma A/S have completed their definitive merger agreement after obtaining the approval of the majority of stockholders as well as completing the relevant regulatory activities. The deal was originally announced on 3 September

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-73555035752725022982009-11-15T16:28:00.002-08:002009-11-15T16:29:03.391-08:00

Abbott announced a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in biologics. PG110 is a novel biologic in phase-I clinical trial development that targets NGF for the treatment of chronic pain. NGF is released at sites of tissue damage

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-57248838736817975962009-11-15T16:28:00.001-08:002009-11-15T16:29:02.057-08:00

Novartis announced the availability of Prevacid 24HR (lansoprazole delayed-release capsules 15 mg/acid reducer) over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn. Prevacid 24HR received US Food and Drug Administration (FDA) approval in May 2009. It is the first and only over-the-counter (OTC) Proton Pump Inhibitor (PPI) for the treatment of frequent

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-27772916645729007812009-11-15T16:28:00.000-08:002009-11-15T16:29:00.940-08:00

Endo Pharmaceuticals has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's US Patent Nos. 5,536,263 and 5,741,510. Endo Pharmaceuticals has agreed to make a one-time, US$ 23 million payment for the exclusive license to these two patents for use in the field of prescription pain medicines and treatment. "We are pleased to add these patents to our

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com0tag:blogger.com,1999:blog-8063331103627450251.post-1398199344764634442009-11-11T07:46:00.000-08:002009-11-11T07:47:02.486-08:00

Simcere Pharmaceutical Group, a developer of branded generic and proprietary pharmaceuticals, has signed an agreement to acquire the manufacturing license in China of rosuvastatin from Tianjin Tianda Pharmaceutical. The acquisition of the manufacturing license will be effected through the acquisition of equity in Tianda as well as transfer of certain technologies from Tianda. Rosuvastatin was

Harbinder Virdihttp://www.blogger.com/profile/16588851724287015496noreply@blogger.com2